Changes in N-glycans of IgG4 and its relationship with the existence of hypocomplementemia and individual organ involvement in patients with IgG4-related disease
Naoki Konno(Fukushima Medical University), Hiroshi Watanabe, Makiko Yashiro Furuya(Fukushima Medical University), Tadayuki Takagi(Fukushima Medical University), Mitsuru Sugimoto(Fukushima Medical University), Hiromasa Ohira(Fukushima Medical University), Kiyoshi Migita(Fukushima Medical University), Atsushi Komatsuda(Akita University), Tomoyuki Asano(Fukushima Medical University), Yoshiaki Miura(Ehime University), Taichi Aihara(Sumitomo Bakelite (Japan)), Hiroko Kobayashi(Fukushima Medical University), Shuzo Sato(Fukushima Medical University)
Cited by 28
Related Papers
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|143
Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists
|Journal of Gastroenterology|2009|132
Ito cell contraction in response to endothelin-1 and substance P
|Hepatology|1993|123